Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist

Details for Australian Patent Application No. 2008219007 (hide)

Owner Merrimack Pharmaceuticals, Inc.

Inventors Briskin, Michael; Stewart, Edward J.

Agent Pizzeys

Pub. Number AU-A-2008219007

PCT Pub. Number WO2008/103378

Priority 60/902,216 20.02.07 US

Filing date 20 February 2008

Wipo publication date 28 August 2008

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/103378 Priority application(s): WO2008/103378

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008219020-Modulation of NKT cell activity with antigen-loaded CDId molecules

2008219006-In vivo hydraulic fixation including biorivets using biocompatible expandable fibers